3DBioFibR Inc. secures $1-million venture capital investment from Invest Nova Scotia

3DBioFibR Inc., a leading manufacturer of advanced biopolymer fibers, has secured a venture capital investment of $1 million from Invest Nova Scotia as part of a $3M financing round.

This investment will support 3DBioFibR to increase manufacturing capacity and operational growth, and implement of ISO 13485 certification.

Over the past two years, 3DBioFibR has secured paid development agreements with a growing roster of global and regional companies designing products in tissue engineering, medical devices, defense, cosmetics, and apparel. The partnerships focus on integrating 3DBioFibR’s best-in-class fibers into existing and emerging product pipelines. The new capital ensures the company can deliver high-performance materials at commercial scale, while laying the groundwork for expanded clinical partnerships.

“As an early investor in 3DBioFibR, Invest Nova Scotia has been active with the company throughout its growth into a unique business that offers novel and unparalleled manufacturing potential for biopolymer applications, representing multibillion-dollar market opportunities,” says Lidija Marušić, Vice President, Business Investment. “With this latest investment, Invest Nova Scotia looks forward to seeing 3DBioFibR achieve their objectives.”

3DBioFibR is driving the adoption of biopolymers, like collagen, chitosan, and spider silk, in regenerative medicine, medical devices, defence, cosmetics, and sustainable textiles. Its patented dry-spinning technology enables scalable, high-precision manufacturing of advanced biopolymer fibers—delivering superior performance at industrial scales.

Invest Nova Scotia invests directly in highly innovative early-stage Nova Scotia companies addressing big challenges – alongside institutional, private sector, and angel investors from Canada and beyond. In addition to capital, Invest Nova Scotia provides hands-on business guidance, supports good governance, helps open doors to co-investors, and facilitates relationships across the start-up, technology, and venture capital ecosystems.

3DBioFibR has also received support through Invest Nova Scotia’s Early-Stage Commercialization Fund, Export Development Program, and Trade Market Intelligence service and currently reside at The Labs at Invest Nova Scotia.

Invest Nova Scotia manages the Nova Scotia First Fund (NSFF), a venture capital fund investing in early-stage Nova Scotia-based technology companies solving big problems for global markets.